HDAC9 and cancer: SFN has been shown to interfere with a key androgen receptor (AR) chaperone, Hsp90, by inhibition of histone deacetylase (HDAC) enzymes, which remove acetyl groups from histones, inhibiting HDAC activity within cancer cell lines [35].